Overview

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil